Fortress Biotech, Inc., 10% Owner at Checkpoint Therapeutics, Inc. (CKPT), sold 6,222,249 shares at $1.29 ($25.2M) on 2025-05-29, disclosed to the SEC on 2025-06-03.
Open-market sale of $25.2M CKPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.29 | 100,000 | $129K | 0.5% |
| 2 | $4.10 | 6,122,249 | $25.1M | 99.5% |
| Total | $4.05 avg | 6,222,249 | $25.2M | 100% |